Comments
Pharma major Dr Reddy’s Laboratories Ltd has launched Ezetimibe and Simvastatin tablets in the US market.
The product is a therapeutic equivalent of generic version of Vytorin (Ezetimibe and Simvastatin) tablets, a registered trademark of MSD International GmbH, the Hyderabad-based Dr Reddy’s said in a release issued here on Thursday.
The drug is indicated along with a proper diet to help lower "bad" cholesterol and fats.
The Vytorin brand had US sales of approximately $678 million for the 12 months ended in February 2017, according to IMS Health.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.